公开(公告)号：US10954348B2

公开(公告)日：2021-03-23

申请号：US16040871

申请日：2018-07-20

申请人： KYUNGPOOK NATIONAL UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION

发明人： Jeongsoo Yoo ,  Woonghee Lee

IPC分类号： C08J3/24 ,  A61K9/51 ,  A61K51/06 ,  B82Y5/00 ,  C08G65/30 ,  C08B37/00 ,  A61K47/69 ,  A61K9/06 ,  A61K49/18 ,  A61K51/12 ,  C08G81/00 ,  C08B15/00 ,  C08L71/02 ,  C08H1/00 ,  C08B33/04 ,  C08B37/18 ,  C08G65/34 ,  B01J19/08 ,  C07H3/06 ,  C08B37/16 ,  C08B37/02 ,  C08B37/08

摘要： The present invention relates to a biocompatible nanoparticle and a use thereof and, more specifically, to a biocompatible nanoparticle formed by irradiation an electron beam to an aqueous solution comprising at least one substance selected from the group consisting of a polysaccharide, a derivative thereof and a polyethylene glycol, thereby inducing inter-molecular cross-linking or intra-molecular cross-linking, and to a use of the biocompatible nanoparticle in a drug carrier, a contrast agent, a diagnostic agent or an intestinal adhesion prevention agent or for disease prevention and treatment.

公开(公告)号：US20180327554A1

公开(公告)日：2018-11-15

申请号：US16040871

申请日：2018-07-20

申请人： KYUNGPOOK NATIONAL UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION

发明人： Jeongsoo Yoo ,  Woonghee Lee

IPC分类号： C08J3/24 ,  A61K47/69 ,  A61K51/12 ,  A61K49/18 ,  C08B37/02 ,  C08G65/34 ,  C08G81/00 ,  C08B37/08 ,  C08B37/00 ,  C08B37/16 ,  C07H3/06 ,  A61K9/06 ,  B01J19/08

CPC分类号： C08J3/246 ,  A61K9/06 ,  A61K47/50 ,  A61K47/6935 ,  A61K47/6939 ,  A61K49/18 ,  A61K49/1818 ,  A61K51/12 ,  A61K51/1244 ,  B01J19/08 ,  B01J19/085 ,  B01J2219/0877 ,  B01J2219/12 ,  B82Y5/00 ,  C07H3/06 ,  C08B37/0006 ,  C08B37/0012 ,  C08B37/0021 ,  C08B37/003 ,  C08B37/0072 ,  C08B37/0084 ,  C08G65/34 ,  C08G81/00 ,  C08G2270/00 ,  C08J2305/00 ,  C08J2305/02 ,  C08J2305/04 ,  C08J2305/08 ,  C08J2305/16

摘要： The present invention relates to a biocompatible nanoparticle and a use thereof and, more specifically, to a biocompatible nanoparticle formed by irradiation an electron beam to an aqueous solution comprising at least one substance selected from the group consisting of a polysaccharide, a derivative thereof and a polyethylene glycol, thereby inducing inter-molecular cross-linking or intra-molecular cross-linking, and to a use of the biocompatible nanoparticle in a drug carrier, a contrast agent, a diagnostic agent or an intestinal adhesion prevention agent or for disease prevention and treatment.